Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2009, Article ID 812102, 8 pages
http://dx.doi.org/10.1155/2009/812102
Clinical Study

Maintained Smoking Cessation for 6 Months Equilibrates the Percentage of Sputum Lymphocyte Cells with That of Nonsmokers

1Department of Thoracic Medicine, University General Hospital, Medical School of the University of Crete, 71110 Heraklion, Greece
2Department of Epidemiology, Social Medicine, Medical School of the University of Crete, 71110 Heraklion, Greece

Received 31 July 2009; Revised 5 November 2009; Accepted 30 November 2009

Academic Editor: Alex Kleinjan

Copyright © 2009 Izolde Bouloukaki et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. M. Sethi and C. L. Rochester, “Smoking and chronic obstructive pulmonary disease,” Clinics in Chest Medicine, vol. 21, no. 1, pp. 67–86, 2000. View at Google Scholar · View at Scopus
  2. The Health Benefits of Smoking Cessation. A Report of the Surgeon General, DHHS Publication, no. (CDC) 90-8416, US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Centers for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Rockville, Md, USA, 1990.
  3. N. M. Siafakas, “In the beginning of COPD: is evolution important?” American Journal of Respiratory and Critical Care Medicine, vol. 175, no. 5, pp. 423–424, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. D. K. Bhalla, F. Hirata, A. K. Rishi, and C. G. Gairola, “Cigarette smoke, inflammation, and lung injury: a mechanistic perspective,” Journal of Toxicology and Environmental Health B, vol. 12, no. 1, pp. 45–64, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Nakata, M. Takahashi, M. Irie, Y. Fujioka, T. Haratani, and S. Araki, “Relationship between cumulative effects of smoking and memory CD4+ T lymphocyte subpopulations,” Addictive Behaviors, vol. 32, no. 7, pp. 1526–1531, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Roos-Engstrand, B. Ekstrand-Hammarström, J. Pourazar, A. F. Behndig, A. Bucht, and A. Blomberg, “Influence of smoking cessation on airway T lymphocyte subsets in COPD,” Journal of Chronic Obstructive Pulmonary Disease, vol. 6, no. 2, pp. 112–120, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. C. M. Skold, E. Blaschke, and A. Eklund, “Transient increases in albumin and hyaluronan in bronchoalveolar lavage fluid after quitting smoking: possible signs of reparative mechanisms,” Respiratory Medicine, vol. 90, no. 9, pp. 523–529, 1996. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Edwards, “Immunological effects of tobacco smoking in “healthy” smokers,” Journal of Chronic Obstructive Pulmonary Disease, vol. 6, no. 1, pp. 48–58, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. A. W. Boots, G. R. M. M. Haenen, and A. Bast, “Oxidant metabolism in chronic obstructive pulmonary disease,” European Respiratory Journal, vol. 22, supplement 46, pp. 14s–27s, 2003. View at Google Scholar · View at Scopus
  10. C. Lensmar, G. Elmberger, M. Skold, and A. Eklund, “Smoking alters the phenotype of macrophages in induced sputum,” Respiratory Medicine, vol. 92, no. 3, pp. 415–420, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Dippolito, A. Foresi, A. Chetta et al., “Eosinophils in induced sputum from asymptomatic smokers with normal lung function,” Respiratory Medicine, vol. 95, no. 12, pp. 969–974, 2001. View at Google Scholar
  12. K. Amin, A. Ekberg-Jansson, C.-G. Lofdahl, and P. Venge, “Relationship between inflammatory cells and structural changes in the lungs of asymptomatic and never smokers: a biopsy study,” Thorax, vol. 58, no. 2, pp. 135–142, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. B. E. A. Lams, A. R. Sousa, P. J. Rees, and T. H. Lee, “Subepithelial immunopathology of the large airways in smokers with and without chronic obstructive pulmonary disease,” European Respiratory Journal, vol. 15, no. 3, pp. 512–516, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Babusyte, K. Stravinskaite, J. Jeroch, J. Lötvall, R. Sakalauskas, and B. Sitkauskiene, “Patterns of airway inflammation and MMP-12 expression in smokers and ex-smokers with COPD,” Respiratory Research, vol. 8, p. 81, 2007. View at Google Scholar
  15. J. M. Wallace, J. S. Oishi, R. G. Barbers, M. S. Simmons, and D. P. Tashkin, “Lymphocytic subpopulation profiles in bronchoalveolar lavage fluid and peripheral blood from tobacco and marijuana smokers,” Chest, vol. 105, no. 3, pp. 847–852, 1994. View at Google Scholar · View at Scopus
  16. G. Chrysofakis, N. Tzanakis, D. Kyriakoy et al., “Perforin expression and cytotoxic activity of sputum CD8+ lymphocytes in patients with COPD,” Chest, vol. 125, no. 1, pp. 71–76, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. U. Costabel, K. J. Bross, C. Reuter, K. H. Rühle, and H. Matthys, “Alterations in immunoregulatory T-cell subsets in cigarette smokers. A phenotypic analysis of bronchoalveolar and blood lymphocytes,” Chest, vol. 90, no. 1, pp. 39–44, 1986. View at Google Scholar · View at Scopus
  18. A. Ekberg-Jansson, B. Andersson, E. Avrå, O. Nilsson, and C. G. Löfdahl, “The expression of lymphocyte surface antigens in bronchial biopsies, bronchoalveolar lavage cells and blood cells in healthy smoking and never-smoking men, 60 years old,” Respiratory Medicine, vol. 94, no. 3, pp. 264–272, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Gadgil and S. R. Duncan, “Role of T-lymphocytes and pro-inflammatory mediators in the pathogenesis of chronic obstructive pulmonary disease,” International Journal of Chronic Obstructive Pulmonary Disease, vol. 3, no. 4, pp. 531–541, 2008. View at Google Scholar
  20. J. L. Wright, J. E. Hobson, B. Wiggs, P. D. Pare, and J. C. Hogg, “Airway inflammation and peribronchiolar attachments in the lungs of nonsmokers, current and ex-smokers,” Lung, vol. 166, no. 5, pp. 277–286, 1988. View at Google Scholar · View at Scopus
  21. J. B. M. Mullen, J. L. Wright, B. R. Wiggs, P. D. Pare, and J. C. Hogg, “Structure of central airways in current smokers and ex-smokers with and without mucus hypersecretion: relationship to lung function,” Thorax, vol. 42, no. 11, pp. 843–848, 1987. View at Google Scholar · View at Scopus
  22. A. Capelli, A. Di Stefano, I. Gnemmi et al., “Increased MCP-1 and MIP-1ß in bronchoalveolar lavage fluid of chronic bronchitics,” European Respiratory Journal, vol. 14, no. 1, pp. 160–165, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Domagała-Kulawik, M. Maskey-Warzechowska, I. Kraszewska, and R. Chazan, “The cellular composition and macrophage phenotype in induced sputum in smokers and ex-smokers with COPD,” Chest, vol. 123, no. 4, pp. 1054–1059, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. C. M. Skold, J. Hed, and A. Eklund, “Smoking cessation rapidly reduces cell recovery in bronchoalveolar lavage fluid, while alveolar macrophage fluorescence remains high,” Chest, vol. 101, no. 4, pp. 989–995, 1992. View at Google Scholar · View at Scopus
  25. G. E. Swan, J. E. Hodgkin, T. Roby, C. Mittman, N. Jacobo, and J. Peters, “Reversibility of airways injury over a 12-month period following smoking cessation,” Chest, vol. 101, no. 3, pp. 607–612, 1992. View at Google Scholar · View at Scopus
  26. B. W. M. Willemse, N. H. T. ten Hacken, B. Rutgers, I. G. Lesman-Leegte, D. S. Postma, and W. Timens, “Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers,” European Respiratory Journal, vol. 26, no. 5, pp. 835–845, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Tsoumakidou, N. Tzanakis, and N. M. Siafakas, “Induced sputum in the investigation of airway inflammation of COPD,” Respiratory Medicine, vol. 97, no. 8, pp. 863–871, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Tsoumakidou, I. Bouloukaki, H. Koutala et al., “Decreased sputum mature dendritic cells in healthy smokers and patients with chronic obstructive pulmonary disease,” International Archives of Allergy and Immunology, vol. 150, no. 4, pp. 389–397, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. S. R. Rutgers, W. Timens, H. F. Kaufmann, Th. W. van der Mark, G. H. Koeter, and D. S. Postma, “Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD,” European Respiratory Journal, vol. 15, no. 1, pp. 109–115, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. J. S. Erjefalt, L. Uller, M. Malm-Erjefalt, and C. G. Persson, “Rapid and efficient clearance of airway tissue granulocytes through transepithelial migration,” Thorax, vol. 59, no. 2, pp. 136–143, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. G. Chrysofakis, N. Tzanakis, D. Kyriakou et al., “Expression of perforin and cytotoxic activity of CD8+ cells in induced sputum from current smokers with COPD,” Pneumon, vol. 15, no. 1, pp. 88–95, 2002. View at Google Scholar
  32. D. Loppow, M. Böttcher, G. Gercken, H. Magnussen, and R. A. Jörres, “Flow cytometric analysis of the effect of dithiothreitol on leukocyted surface markers,” European Respiratory Journal, vol. 16, no. 2, pp. 324–329, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. K. C. Meyer, W. Ershler, N. S. Rosenthal, X.-G. Lu, and K. Peterson, “Immune dysregulation in the aging human lung,” American Journal of Respiratory and Critical Care Medicine, vol. 153, no. 3, pp. 1072–1079, 1996. View at Google Scholar · View at Scopus
  34. K. C. Meyer and P. Soergel, “Variation of bronchoalveolar lymphocyte phenotypes with age in the physiologically normal human lung,” Thorax, vol. 54, no. 8, pp. 697–700, 1999. View at Google Scholar · View at Scopus